Hubei Guangji Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 674.48 million compared to CNY 476.33 million a year ago. Net income was CNY 19.91 million compared to CNY 74.18 million a year ago.

Basic earnings per share from continuing operations was CNY 0.0564 compared to CNY 0.2156 a year ago. Diluted earnings per share from continuing operations was CNY 0.0577 compared to CNY 0.2156 a year ago.